Zenobia Therapeutics, Inc.

San Diego, CA

UEI
LPJTA7TN4LS8
CAGE
542U8
Primary NAICS
611710 Educational Support Services
SAM.gov registration
Active through

Company facts

FY2025 rankings
Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
10054 Mesa Ridge Ct Suite 106, San Diego, CA 92121, USA
Founded
2008
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $250,000

Contract awards

Award Agency Obligated Awarded
Small business innovation research (SBIR) 2025 phase IB award 91990025C0082 Contracts and Acquisition Management $250,000
Drugs and biologicals HHSN261201500774PC National Cancer Institute (NIH) $7,500

Grant awards

SBA capabilities narrative

Provider of fragment screening libraries for drug discovery and services supporting fragment screening and structural biology through Zenobia Fragments. Zenobia Therapeutics focus is Parkinson's disease research.

Quick answers

Is Zenobia Therapeutics, Inc. registered in SAM.gov?

Yes. Zenobia Therapeutics, Inc.'s SAM.gov registration is active through April 7, 2027.

What is Zenobia Therapeutics, Inc.'s CAGE code?

Zenobia Therapeutics, Inc.'s CAGE code is 542U8, and its Unique Entity ID (UEI) is LPJTA7TN4LS8.

How much has Zenobia Therapeutics, Inc. received in federal contracts?

Federal contracts obligated $250,000 to Zenobia Therapeutics, Inc. in fiscal year 2025.

How does Zenobia Therapeutics, Inc. rank among federal contractors?

Zenobia Therapeutics, Inc. ranked #43 in PSC AF11 and #62 in PSC AF in FY2025.

What is Zenobia Therapeutics, Inc.'s most recent federal award?

Zenobia Therapeutics, Inc.'s most recent federal contract award is Small business innovation research (SBIR) 2025 phase IB award (91990025C0082), from Contracts and Acquisition Management, on September 12, 2025.

On GovTribe

See Zenobia Therapeutics, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe